Amid the federal funding uncertainty for health and sciences, local life science leaders say this could be a moment for industry partners, investors and others to step up and support the sector.

A 3D model accurately mimicking the blood-brain barrier (BBB) in a laboratory environment has been successfully developed by ...

The Phase 1b/2a study will assess the safety of CNP-103 in adults (aged 18-35) and pediatrics (aged 12-17) who have Stage III or newly diagnosed (within the last 6 months) T1D as well as C-peptide ...

The Graduate Aptitude Test-Biotechnology (GAT-B) 2025 application period is now open at exams.nta.ac.in/DBT, according to the ...

The National Testing Agency (NTA) has commenced the registration process for the Graduate Aptitude Test – Biotechnology ...

PHILADELPHIA and VANCOUVER, British Columbia - BriaCell Therapeutics Corp., a clinical-stage biotechnology company specializing in immunotherapies for cancer care, announced today its plans to conduct ...

Collaboration to explore the immunoregulation of NK and T cells within the tumor microenvironment (TME) by CAPTN-3, with the goal of enhancing ...

Delve into the increasingly dynamic landscape of ALS treatment development with thirteen companies advancing candidates in ...

There’s also the possibility that “A Quiet Place 3” could introduce new characters in a different location, still under siege from the same breed of marauding predators from the OG films.

The Bureau of Industry and Security is placing new export controls on certain laboratory equipment that can be used for biotechnology purposes that may threaten U.S. national security, the agency said ...

The most advanced, and arguably important, program in the pipeline is OST-HER2, an engineered form of the bacteria Listeria ... even though we have a 33.3% response rate just announced.

Sign up to read this article for free. Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.